Home
Scholarly Works
Why do patients with metastatic breast cancer...
Conference

Why do patients with metastatic breast cancer (MBC) continue to have bone destruction despite bisphosphonate (BP) use? A pathologic review

Authors

Ooi WS; Gainford C; Kahn H; Kalina M; Popovic S; Singh G; Clemons M

Volume

38

Publisher

Elsevier

Publication Date

March 1, 2006

DOI

10.1016/j.bone.2006.01.044

Conference proceedings

Bone

Issue

3

ISSN

8756-3282

Contact the Experts team